Year |
Citation |
Score |
2018 |
Torres-Ayuso P, Sahoo S, Ashton G, An E, Simms N, Galvin M, Leong HS, Frese KK, Simpson K, Cook N, Hughes A, Miller CJ, Marais R, Dive C, Krebs MG, et al. Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin. Npj Genomic Medicine. 3: 15. PMID 29951225 DOI: 10.1038/S41525-018-0055-6 |
0.306 |
|
2017 |
Anderson KJ, de Guillebon A, Hughes A, Wang W, King MR. Effect of circulating tumor cell aggregate configuration on hemodynamic transport and wall contact. Mathematical Biosciences. PMID 29024748 DOI: 10.1016/J.Mbs.2017.10.002 |
0.677 |
|
2016 |
Carter L, Rothwell DG, Mesquita B, Smowton C, Leong HS, Fernandez-Gutierrez F, Li Y, Burt DJ, Antonello J, Morrow CJ, Hodgkinson CL, Morris K, Priest L, Carter M, Miller C, ... Hughes A, et al. Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nature Medicine. PMID 27869802 DOI: 10.1038/nm.4239 |
0.326 |
|
2016 |
Williamson SC, Metcalf RL, Trapani F, Mohan S, Antonello J, Abbott B, Leong HS, Chester CP, Simms N, Polanski R, Nonaka D, Priest L, Fusi A, Carlsson F, Carlsson A, ... ... Hughes A, et al. Vasculogenic mimicry in small cell lung cancer. Nature Communications. 7: 13322. PMID 27827359 DOI: 10.1038/Ncomms13322 |
0.342 |
|
2015 |
Hughes A, Marsh G, Waugh RE, Foster DG, King MR. Halloysite nanotube coatings suppress leukocyte spreading. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 26605493 DOI: 10.1021/Acs.Langmuir.5B03288 |
0.514 |
|
2014 |
Hedges EA, Hughes AD, Liesveld JL, King MR. Modulation of selectin-mediated adhesion of flowing lymphoma and bone marrow cells by immobilized SDF-1. International Journal of Molecular Sciences. 15: 15061-72. PMID 25167133 DOI: 10.3390/Ijms150915061 |
0.554 |
|
2014 |
Hughes AD, Marshall JR, Keller E, Powderly JD, Greene BT, King MR. Differential drug responses of circulating tumor cells within patient blood. Cancer Letters. 352: 28-35. PMID 23973263 DOI: 10.1016/J.Canlet.2013.08.026 |
0.63 |
|
2013 |
Geng Y, Chandrasekaran S, Hsu JW, Gidwani M, Hughes AD, King MR. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. Plos One. 8: e54959. PMID 23372803 DOI: 10.1371/Journal.Pone.0054959 |
0.656 |
|
2012 |
Greene BT, Hughes AD, King MR. Circulating tumor cells: the substrate of personalized medicine? Frontiers in Oncology. 2: 69. PMID 22783545 DOI: 10.3389/Fonc.2012.00069 |
0.59 |
|
2012 |
Hughes AD, Mattison J, Powderly JD, Greene BT, King MR. Rapid isolation of viable circulating tumor cells from patient blood samples. Journal of Visualized Experiments : Jove. e4248. PMID 22733259 DOI: 10.3791/4248 |
0.617 |
|
2012 |
Mitchell MJ, Chen CS, Ponmudi V, Hughes AD, King MR. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 160: 609-17. PMID 22421423 DOI: 10.1016/J.Jconrel.2012.02.018 |
0.663 |
|
2012 |
Hughes AD, Mattison J, Western LT, Powderly JD, Greene BT, King MR. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clinical Chemistry. 58: 846-53. PMID 22344286 DOI: 10.1373/Clinchem.2011.176669 |
0.614 |
|
2012 |
Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, Ranson M, Blackhall FH, Dive C. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 306-15. PMID 22173704 DOI: 10.1097/JTO.0b013e31823c5c16 |
0.42 |
|
2012 |
Hughes AD, King MR. Nanobiotechnology for the capture and manipulation of circulating tumor cells. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 4: 291-309. PMID 22162415 DOI: 10.1002/Wnan.168 |
0.623 |
|
2011 |
Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G, Ranson M, Dive C, Blackhall FH. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1556-63. PMID 21422424 DOI: 10.1200/JCO.2010.28.7045 |
0.344 |
|
2011 |
Hou JM, Krebs M, Ward T, Sloane R, Priest L, Hughes A, Clack G, Ranson M, Blackhall F, Dive C. Circulating tumor cells as a window on metastasis biology in lung cancer. The American Journal of Pathology. 178: 989-96. PMID 21356352 DOI: 10.1016/j.ajpath.2010.12.003 |
0.457 |
|
2010 |
Hughes AD, King MR. Use of naturally occurring halloysite nanotubes for enhanced capture of flowing cells. Langmuir : the Acs Journal of Surfaces and Colloids. 26: 12155-64. PMID 20557077 DOI: 10.1021/La101179Y |
0.6 |
|
2010 |
Percec V, Wilson DA, Leowanawat P, Wilson CJ, Hughes AD, Kaucher MS, Hammer DA, Levine DH, Kim AJ, Bates FS, Davis KP, Lodge TP, Klein ML, DeVane RH, Aqad E, et al. Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures. Science (New York, N.Y.). 328: 1009-14. PMID 20489021 DOI: 10.1126/Science.1185547 |
0.384 |
|
2009 |
Hou JM, Greystoke A, Lancashire L, Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A, Ranson M, Lorigan P, Dive C, Blackhall FH. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. The American Journal of Pathology. 175: 808-16. PMID 19628770 DOI: 10.2353/ajpath.2009.090078 |
0.397 |
|
Show low-probability matches. |